Accelerated progression from mild cognitive impairment to dementia in people with diabetes

Diabetes

Volumn 59, Issue 11, 2010, Pages 2928-2935

  Xu, Weili ^a,b   Caracciolo, Barbara ^a   Wang, Hui Xin ^a   Winblad, Bengt ^a   Bäckman, Lars ^a   Qiu, Chengxuan ^a   Fratiglioni, Laura ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c STOCKHOLM GERONTOLOGY RESEARCH CENTER   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; GLUCOSE;

AGED; ARTICLE; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; DRUG USE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; SURVIVAL;

AGED; AGED, 80 AND OVER; AMNESIA; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DEMENTIA; DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE PROGRESSION; EDUCATIONAL STATUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; PREDIABETIC STATE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 78049274928     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-0539     Document Type: Article

References (50)

1. Biessels GJ, Kerssen A, de Haan EH, Kappelle LJ. Cognitive dysfunction and diabetes: implications for primary care. Prim Care Diabetes 2007;1: 187-193
2. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5: 64-74 (Pubitemid 41790697)
3. Akomolafe A, Beiser A, Meigs JB, Au R, Green RC, Farrer LA, Wolf PA, Seshadri S. Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study. Arch Neurol 2006;63:1551-1555
4. Strachan MW, Price JF, Frier BM. Diabetes, cognitive impairment, and dementia. BMJ 2008;336:6
5. Xu W, Qiu C, Winblad B, Fratiglioni L. The effect of borderline diabetes on the risk of dementia and Alzheimer's disease. Diabetes 2007;56:211-216
6. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004;63:658-663
7. Saczynski JS, Jonsdottir MK, Garcia ME, Jonsson PV, Peila R, Eiriksdottir G, Olafsdottir E, Harris TB, Gudnason V, Launer LJ. Cognitive impairment: an increasingly important complication of type 2 diabetes: the age, gene/environment susceptibility-Reykjavik study. Am J Epidemiol 2008; 168:1132-1139
8. Roberts RO, Geda YE, Knopman DS, Christianson TJ, Pankratz VS, Boeve BF, Vella A, Rocca WA, Petersen RC. Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol 2008;65: 1066-1073
9. Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R. Relation of diabetes to mild cognitive impairment. Arch Neurol 2007;64:570-575 (Pubitemid 46588347)
10. Solfrizzi V, Panza F, Colacicco AM, D'Introno A, Capurso C, Torres F, Grigoletto F, Maggi S, Del PA, Reiman EM, Caselli RJ, Scafato E, Farchi G, Capurso A. Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 2004;63:1882-1891
11. Ganguli M, Petersen RC. Mild cognitive impairment: challenging issues. Am J Geriatr Psychiatry 2008;16:339-342
12. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de LM, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van DC, Visser P, Petersen RC. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240-246
13. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de LM, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B. Mild cognitive impairment. Lancet 2006;367:1262-1270
14. Petersen RC, Negash S. Mild cognitive impairment: an overview. CNS Spectr 2008;13:45-53
15. Caracciolo B, Palmer K, Monastero R, Winblad B, Backman L, Fratiglioni L. Occurrence of cognitive impairment and dementia in the community: a 9-year-long prospective study. Neurology 2008;70:1778-1785
16. Palmer K, Backman L, Winblad B, Fratiglioni L. Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease. Am J Geriatr Psychiatry 2008;16:603-611
17. Artero S, Ancelin ML, Portet F, Dupuy A, Berr C, Dartigues JF, Tzourio C, Rouaud O, Poncet M, Pasquier F, Auriacombe S, Touchon J, Ritchie K. Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry 2008;79:979-984
18. Xu W, Qiu C, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes 2009;58:71-77
19. Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology 2004;63:1181-1186
20. Xu WL, von SE, Qiu CX, Winblad B, Fratiglioni L. Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study. Diabetologia 2009;52:1031-1039
21. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 1997;48:132-138
22. Fratiglioni L, Grut M, Forsell Y, Viitanen M, Winblad B. Clinical diagnosis of Alzheimer's disease and other dementias in a population survey. Agreement and causes of disagreement in applying Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition, criteria. Arch Neurol 1992;49:927-932
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed.-Revised (DSM-III-R). Washington, DC: American Psychiatric Association, 1987
24. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992
25. Fratiglioni L, Viitanen M, Backman L, Sandman PO, Winblad B. Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology 1992;11 (Suppl. 1):29-36
26. Qiu C, Backman L, Winblad B, Aguero-Torres H, Fratiglioni L. The influence of education on clinically diagnosed dementia incidence and mortality data from the Kungsholmen Project. Arch Neurol 2001;58:2034-2039
27. Nordic Council on Medicines. Guidelines for ATC Classification. Uppsala, Sweden, Nordic Council on Medicines (NLN Publication No. 16), 1985
28. Qiu C, Kivipelto M, Aguero-Torres H, Winblad B, Fratiglioni L. Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen Project: variation by age and sex. J Neurol Neurosurg Psychiatry 2004;75:828-833
29. World Health Organization. Definition, Diabetes and Classification of Diabetes Mellitus and Its Complications. Geneva, World Health Organization, 1999
30. Petersen RC, Morris JC. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 2005;62:1160-1163
31. Wahlin A, Backman L, Winblad B. Free recall and recognition of slowly and rapidly presented words in very old age: a community-based study. Exp Aging Res 1995;21:251-271
32. Larrieu S, Letenneur L, Orgogozo JM, Fabrigoule C, Amieva H, Le CN, Barberger-Gateau P, Dartigues JF. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 2002;59:1594-1599
33. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, Russell RW, Symon L. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-637
34. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944
35. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260
36. van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ. Brain imaging in patients with diabetes: a systematic review. Diabetes Care 2006;29:2539-2548 (Pubitemid 44912267)
37. Korf ES, White LR, Scheltens P, Launer LJ. Brain aging in very old men with type 2 diabetes: the Honolulu-Asia Aging Study. Diabetes Care 2006;29:2268-2274
38. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007;69:2197-2204
39. Qiu WQ, Folstein MF. Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease: review and hypothesis. Neurobiol Aging 27:2006;27:190-198
40. Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 2004;53: 474-481
41. Cukierman-Yaffe T, Gerstein HC, Williamson JD, Lazar RM, Lovato L, Miller ME, Coker LH, Murray A, Sullivan MD, Marcovina SM, Launer LJ. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care 2009;32:221-226
42. Cole AR, Astell A, Green C, Sutherland C. Molecular connexions between dementia and diabetes. Neurosci Biobehav Rev 2007;31:1046-1063
43. Lamport DJ, Lawton CL, Mansfield MW, Dye L. Impairments in glucose tolerance can have a negative impact on cognitive function: a systematic research review. Neurosci Biobehav Rev 2009;33:394-413
44. Euser SM, Sattar N, Witteman JC, Bollen EL, Sijbrands EJ, Hofman A, Perry IJ, Breteler MM, Westendorp RG. A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from the PROSPER and Rotterdam studies. Diabetes 2010;59:1601-1607
45. Toro P, Schonknecht P, Schroder J. Type II Diabetes in mild cognitive impairment and Alzheimer's disease: Results from a prospective population-based study in Germany. J Alzheimers Dis 2009;16:687-691
46. van den Berg E, de Craen AJ, Biessels GJ, Gussekloo J, Westendorp RG. The impact of diabetes mellitus on cognitive decline in the oldest of the old: a prospective population-based study. Diabetologia 2006;49:2015-2023
47. Andersson DK, Svardsudd K, Tibblin G. Prevalence and incidence of diabetes in a Swedish community 1972-1987. Diabet Med 1991;8:428-434
48. Xu W. Diabetes mellitus and the risk of dementia: a population-based study. Karolinska Institutet. The frame of the thesis available at http://diss.kib.ki.se/2008/978 -91-7357-516-4. Accessed 16 May 2008
49. Hunderfund AL, Roberts RO, Slusser TC, Leibson CL, Geda YE, Ivnik RJ, Tangalos EG, Petersen RC. Mortality in amnestic mild cognitive impairment: a prospective community study. Neurology 2006;67:1764-1768
50. Viswanathan A, Rocca WA, Tzourio C. Vascular risk factors and dementia: how to move forward? Neurology 2009;72:368-374